Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

149
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
149
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

154
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
154
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

198
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
198
Management of Insomnia01:19

Management of Insomnia

234
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
234
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

285
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
285
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
147

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Advancing in-hospital mortality prediction for acute myocardial infarction: An analysis from the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.

American heart journal·2026
Same author

Neuraxial anesthesia for surgical pregnancy termination in patients with severe pulmonary hypertension: a case series (2019-2025).

International journal of obstetric anesthesia·2026
Same author

Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium.

Journal of the American Heart Association·2026
Same author

The Contemporary Landscape of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

A New Drug for Resistant Hypertension: Aprocitentan.

Current hypertension reviews·2026
Same author

Myocardial Ischemia-Associated Arterial Embolism Management from Pulmonary Cryotherapy.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2025
Same journal

Something Old and Plenty New in Advances in Anesthesia 2025.

Advances in anesthesia·2025
Same journal

Highlights of Point-Of-Care Ultrasound for the Anesthesiologist.

Advances in anesthesia·2025
Same journal

The Current Use of Artificial Intelligence in Anesthesiology.

Advances in anesthesia·2025
Same journal

Implementation of an Acute Pain Management Service in Private Practice: Quality Improvement- Success and Challenges.

Advances in anesthesia·2025
Same journal

Perioperative Management of Noncardiac Implanted Medical Devices.

Advances in anesthesia·2025
Same journal

Extending the Duration of Your Peripheral Nerve Block: From Perineural Additives and Continuous Catheters, to Liposomal Preparations and Beyond.

Advances in anesthesia·2025
查看所有相关文章

相关实验视频

Updated: Jun 9, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

8.8K

雷米马佐拉姆 (Remimazolam) 是一种药物.

Miguel T Teixeira1, Abhinav Goyal2

  • 1Department of Anesthesiology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.

Advances in anesthesia
|October 23, 2024
PubMed
概括
此摘要是机器生成的。

雷米马佐拉姆是一种新型的二,提供快速镇静和快速恢复,具有安全的特征. 其有利的药理动力学使其成为现有的静脉静止剂的有希望的替代品.

关键词:
麻醉 麻醉是一种麻醉.二二胺类药物中的一种.催眠 催眠是一种催眠.药理动力学 药理动力学药理学 药理学是指药理学的学科.雷米马佐拉姆 (Remimazolam) 是一种药物.镇静剂 - 麻醉剂 麻醉剂

更多相关视频

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

892

相关实验视频

Last Updated: Jun 9, 2025

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

8.8K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

892

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 麻醉学 麻醉学
  • 临床药房 临床药房

背景情况:

  • 静脉静止剂对于程序静止和麻醉至关重要.
  • 现有的药物,如普罗波福和米达佐拉姆,在康复时间和心肺作用方面存在局限性.
  • 需要具有更好的安全性和药理动力学特征的镇静剂.

研究的目的:

  • 为了引入remimazolam,一种新的静脉静止剂.
  • 为了突出其与其他镇静剂相比独特的特性.
  • 讨论其潜在的临床应用.

主要方法:

  • 雷米马佐拉姆是一种可逆的GABA-A激动剂,二胺.
  • 它是静脉注射的.
  • 评估其药理动力学和安全性概况.

主要成果:

  • 雷米马佐拉姆显示出迅速开始起作用.
  • 它提供了短时间的效果和快速恢复.
  • 该药物表现出安全的心肺状况.
  • 与其他静脉注射镇静剂相比,观察到有利的药理动力学.

结论:

  • 雷米马佐拉姆在静脉静止时具有有利的安全性和药理动力学特征.
  • 它的迅速发病和恢复使其成为临床实践中潜在的有价值的药物.
  • 雷米马佐拉姆可能比现有的静脉静止剂具有优势.